- Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a range of $3.80 to $3.85

MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ - Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2009, income from continuing operations rose to $192 million, or $1.02 per diluted share, from $160 million, or $0.81 per diluted share, for the third quarter of 2008. In 2008, third quarter results were reduced by a $0.03 per share charge associated with the write-down of an equity investment, and a $0.02 per share impact associated with hurricanes.